OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 813 citing articles:

The Immune Landscape of Cancer
Vésteinn Thórsson, David L. Gibbs, Scott D. Brown, et al.
Immunity (2018) Vol. 48, Iss. 4, pp. 812-830.e14
Open Access | Times Cited: 4557

xCell: digitally portraying the tissue cellular heterogeneity landscape
Dvir Aran, Zicheng Hu, Atul J. Butte
Genome biology (2017) Vol. 18, Iss. 1
Open Access | Times Cited: 3350

Renal cell carcinoma
James J. Hsieh, Mark P. Purdue, Sabina Signoretti, et al.
Nature Reviews Disease Primers (2017) Vol. 3, Iss. 1
Open Access | Times Cited: 2085

Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
Elham Azizi, Ambrose Carr, George Plitas, et al.
Cell (2018) Vol. 174, Iss. 5, pp. 1293-1308.e36
Open Access | Times Cited: 1687

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
Diana Miao, Claire A. Margolis, Wenhua Gao, et al.
Science (2018) Vol. 359, Iss. 6377, pp. 801-806
Open Access | Times Cited: 1067

Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data
Julien Racle, Kaat de Jonge, Petra Baumgaertner, et al.
eLife (2017) Vol. 6
Open Access | Times Cited: 1058

Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
Samra Turajlic, Kevin Litchfield, Hang Xu, et al.
The Lancet Oncology (2017) Vol. 18, Iss. 8, pp. 1009-1021
Open Access | Times Cited: 821

Conserved pan-cancer microenvironment subtypes predict response to immunotherapy
Alexander Bagaev, Nikita Kotlov, Krystle Nomie, et al.
Cancer Cell (2021) Vol. 39, Iss. 6, pp. 845-865.e7
Open Access | Times Cited: 818

Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures
Dongqiang Zeng, Meiyi Li, Rui Zhou, et al.
Cancer Immunology Research (2019) Vol. 7, Iss. 5, pp. 737-750
Open Access | Times Cited: 770

Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
Junfei Zhao, Andrew Chen, Robyn D. Gartrell, et al.
Nature Medicine (2019) Vol. 25, Iss. 3, pp. 462-469
Open Access | Times Cited: 736

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
C. Ricketts, Aguirre A. de Cubas, Huihui Fan, et al.
(2018)
Open Access | Times Cited: 671

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
C. Ricketts, Aguirre A. de Cubas, Huihui Fan, et al.
Cell Reports (2018) Vol. 23, Iss. 1, pp. 313-326.e5
Open Access | Times Cited: 632

B cells, plasma cells and antibody repertoires in the tumour microenvironment
Г. В. Шаронов, Ekaterina O. Serebrovskaya, Diana V. Yuzhakova, et al.
Nature reviews. Immunology (2020) Vol. 20, Iss. 5, pp. 294-307
Closed Access | Times Cited: 505

The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications
W. Marston Linehan, Christopher J. Ricketts
Nature Reviews Urology (2019) Vol. 16, Iss. 9, pp. 539-552
Closed Access | Times Cited: 489

Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies
Roberta Zappasodi, Taha Merghoub, Jedd D. Wolchok
Cancer Cell (2018) Vol. 33, Iss. 4, pp. 581-598
Open Access | Times Cited: 467

Cancer stemness, intratumoral heterogeneity, and immune response across cancers
Alex Miranda, Phineas T. Hamilton, Allen W. Zhang, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 18, pp. 9020-9029
Open Access | Times Cited: 453

Clear cell renal cell carcinoma ontogeny and mechanisms of lethality
Eric Jonasch, Cheryl L. Walker, W. Kimryn Rathmell
Nature Reviews Nephrology (2020) Vol. 17, Iss. 4, pp. 245-261
Open Access | Times Cited: 449

Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
Kevin Bi, Meng Xiao He, Ziad Bakouny, et al.
Cancer Cell (2021) Vol. 39, Iss. 5, pp. 649-661.e5
Open Access | Times Cited: 427

Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient
Alejandro Jiménez-Sánchez, Danish Memon, Stephane Pourpe, et al.
Cell (2017) Vol. 170, Iss. 5, pp. 927-938.e20
Open Access | Times Cited: 418

Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer
Sri Krishna, Frank J. Lowery, Amy R. Copeland, et al.
Science (2020) Vol. 370, Iss. 6522, pp. 1328-1334
Open Access | Times Cited: 415

Genomic correlates of response to immune checkpoint blockade
Tanya E. Keenan, Kelly P. Burke, Eliezer M. Van Allen
Nature Medicine (2019) Vol. 25, Iss. 3, pp. 389-402
Open Access | Times Cited: 413

Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade
Robert J. Motzer, Romain Banchereau, Habib Hamidi, et al.
Cancer Cell (2020) Vol. 38, Iss. 6, pp. 803-817.e4
Open Access | Times Cited: 401

Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer
Qingzhu Jia, Wei Wu, Yuqi Wang, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 393

Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)
Patrick Danaher, Sarah Warren, Rongze Lu, et al.
Journal for ImmunoTherapy of Cancer (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 361

Page 1 - Next Page

Scroll to top